Summary of an Evidence Brief in preparation
Download the preliminary summary (2 pp. 720 kB) at:
Pharmaceutical manufacturing in Sub-Saharan Africa (SSA) is – contrary to external perceptions – long established. African governments and other actors including the African Union Commission, NEPAD and the East African Community are actively promoting industrial development in pharmaceuticals, supported by UN and other international partners including BMZ. At the same time, low income SSA populations suffer inadequate health care undermined by poor access to medicines. In the context of SDG3 and international commitments to universal health coverage (UHC), international intervention finances large scale international procurement of medicines and supports health system strengthening.